These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 25307706

  • 1. Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients.
    Halle BM, Poulsen TD, Pedersen HP.
    Acta Anaesthesiol Scand; 2014 Nov; 58(10):1214-9. PubMed ID: 25307706
    [Abstract] [Full Text] [Related]

  • 2. Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients.
    Sakka SG.
    J Clin Monit Comput; 2018 Oct; 32(5):787-796. PubMed ID: 29039062
    [Abstract] [Full Text] [Related]

  • 3. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study.
    Memiş D, Kargi M, Sut N.
    J Crit Care; 2009 Dec; 24(4):603-8. PubMed ID: 19931154
    [Abstract] [Full Text] [Related]

  • 4. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients.
    Reekers M, Simon MJ, Boer F, Mooren RA, van Kleef JW, Dahan A, Vuyk J.
    Anesth Analg; 2010 Feb 01; 110(2):466-72. PubMed ID: 20081133
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT, Memiş D, Kargi M, Sut N.
    J Crit Care; 2009 Sep 01; 24(3):329-34. PubMed ID: 19327336
    [Abstract] [Full Text] [Related]

  • 6. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM, Cywinski JB, Alster JM, Irefin SA, Popovich M, Beven M, Fung JJ.
    Liver Transpl; 2008 Jan 01; 14(1):46-52. PubMed ID: 18161838
    [Abstract] [Full Text] [Related]

  • 7. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À, Mas A, Fernández J, García-Valdecasas JC.
    Transplant Proc; 2012 Jan 01; 44(6):1539-41. PubMed ID: 22841207
    [Abstract] [Full Text] [Related]

  • 8. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E, Saliba F, Benhamida S, Ichaï P, Azoulay D, Adam R, Castaing D, Samuel D.
    Liver Transpl; 2009 Oct 01; 15(10):1358-64. PubMed ID: 19790157
    [Abstract] [Full Text] [Related]

  • 9. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients.
    Sakka SG, van Hout N.
    Intensive Care Med; 2006 May 01; 32(5):766-9. PubMed ID: 16544120
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.
    Sakka SG, Reinhart K, Meier-Hellmann A.
    Chest; 2002 Nov 01; 122(5):1715-20. PubMed ID: 12426276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M.
    Liver Int; 2009 Nov 01; 29(10):1516-20. PubMed ID: 19732329
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Indocyanine green disappearance rate is the most useful marker for liver resection.
    Scheingraber S, Richter S, Igna D, Flesch S, Kopp B, Schilling MK.
    Hepatogastroenterology; 2008 Nov 01; 55(85):1394-9. PubMed ID: 18795697
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.
    Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C.
    BMC Gastroenterol; 2009 Dec 03; 9():91. PubMed ID: 19954554
    [Abstract] [Full Text] [Related]

  • 18. Current use and perspective of indocyanine green clearance in liver diseases.
    Levesque E, Martin E, Dudau D, Lim C, Dhonneur G, Azoulay D.
    Anaesth Crit Care Pain Med; 2016 Feb 03; 35(1):49-57. PubMed ID: 26477363
    [Abstract] [Full Text] [Related]

  • 19. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ.
    Hepatobiliary Pancreat Dis Int; 2009 Feb 03; 8(1):46-9. PubMed ID: 19208514
    [Abstract] [Full Text] [Related]

  • 20. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR, El-Desoky AA, Seifalian AM, Habib N, Davidson BR.
    Br J Surg; 2000 May 03; 87(5):568-74. PubMed ID: 10792311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.